May 14, 2020 / 10:54 AM / 19 days ago

BRIEF-Biomx Inc Says Results From Phase 2 Cosmetic Clinical Study Of BX001 Expected In Q2 Of 2021

May 14 (Reuters) - Biomx Inc:

* BIOMX REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* BIOMX INC - CASH AND EQUIVALENTS OF $75.3 MILLION EXPECTED TO FUND CURRENT OPERATING PLAN FOR AT LEAST 24 MONTHS

* BIOMX INC - RESULTS FROM PHASE 2 COSMETIC CLINICAL STUDY OF BX001 EXPECTED IN Q2 OF 2021

* BIOMX INC - BIOMX’S GUIDANCE ON TIMING OF CERTAIN CLINICAL MILESTONES HAS EVOLVED

* BIOMX INC - CASH BALANCE AND SHORT-TERM DEPOSITS AS OF MARCH 31, 2020, WERE $75.3 MILLION, COMPARED TO $82.3 MILLION AS OF DECEMBER 31, 2019 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below